Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7884.06% is 11% above its 5-year average of -8816.24%, near the high end of its 5-year range (-30109.76%–-2969.55%).
37.29% above its 12-month average of -12572.21%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -8876.92%.
NET PROFIT MARGIN
-7884.06%
NET PROFIT MARGIN AVG TTM
-12572.21%
NET PROFIT MARGIN AVG 3Y
-7948.90%
NET PROFIT MARGIN AVG 5Y
-8816.24%
NET PROFIT MARGIN AVG 10Y
-7520.90%
NET PROFIT MARGIN AVG 15Y
-6706.77%
NET PROFIT MARGIN AVG 20Y
-6231.60%
CURRENT VS TTM AVG
+37.29%
CURRENT VS 3Y AVG
+0.82%
CURRENT VS 5Y AVG
+10.57%
CURRENT VS 10Y AVG
-4.83%
CURRENT VS 15Y AVG
-17.55%
CURRENT VS 20Y AVG
-26.52%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cardiff Oncology, Inc.
Market Cap
$83.24M
Net Profit Margin
-7884.06%
TTM Avg
-12572.21%
3Y Avg
-7948.90%
5Y Avg
-8816.24%
Market Cap
$82.78M
Net Profit Margin
57.57%
TTM Avg
-58.69%
3Y Avg
-51.95%
5Y Avg
-56.60%
Market Cap
$83.63M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.82M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.31M
Net Profit Margin
-1168.20%
TTM Avg
-1464.39%
3Y Avg
-946.48%
5Y Avg
-672.82%
Market Cap
$84.32M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$84.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-72272.26%
Market Cap
$84.57M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.36M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $83.24M | -7884.06% | -12572.21% | -7948.90% | -8816.24% |
| LENSAR Inc (LNSR)vs › | $82.78M | 57.57% | -58.69% | -51.95% | -56.60% |
| Citius Oncology, Inc. (CTOR)vs › | $83.63M | -648.32% | 0.00% | 0.00% | 0.00% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| MediciNova, Inc. (MNOV)vs › | $82.31M | -1168.20% | -1464.39% | -946.48% | -672.82% |
| Humacyte, Inc. (HUMA)vs › | $84.32M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.52M | 0.00% | 0.00% | 0.00% | -72272.26% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $82.36M | -430.43% | -446.97% | -347.08% | -386.84% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.42M | -269.42% | -19.58% | -904.79% | -881.91% |
Operating Margin
-8256.3%
Net Profit Margin
-7884.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -8876.92% |
| 2026-03-31 | -30109.76% |
| 2025-12-31 | -2969.55% |
| 2025-09-30 | -9381.67% |
| 2025-06-30 | -11523.14% |
| 2025-03-31 | -12324.77% |
| 2024-12-31 | -7805.96% |
| 2024-09-30 | -7184.85% |
| 2024-06-30 | -7225.77% |
| 2024-03-31 | -4883.41% |
| 2023-12-31 | -5985.26% |
| 2023-09-30 | -6901.42% |
| 2023-06-30 | -10324.07% |
| 2023-03-31 | -13521.69% |
| 2022-12-31 | -6794.53% |
| 2022-09-30 | -9216.13% |
| 2022-06-30 | -11475.82% |
| 2022-03-31 | -14855.41% |
| 2021-12-31 | -7099.25% |
| 2021-09-30 | -8038.37% |
| 2021-06-30 | -9936.76% |
| 2021-03-31 | -7193.06% |
| 2020-12-31 | -5531.88% |
| 2020-09-30 | -3306.62% |
| 2020-06-30 | -9590.70% |
| 2020-03-31 | -6013.24% |
| 2019-12-31 | -4582.71% |
| 2019-09-30 | -8012.75% |
| 2019-06-30 | -2989.13% |
| 2019-03-31 | -2410.49% |
| 2018-12-31 | -5332.05% |
| 2018-09-30 | -4266.10% |
| 2018-06-30 | -3351.09% |
| 2018-03-31 | -4779.68% |
| 2017-12-31 | -1389.19% |
| 2017-09-30 | -3480.09% |
| 2017-06-30 | -7887.20% |
| 2017-03-31 | -10521.62% |
| 2016-12-31 | -12570.59% |
| 2016-09-30 | -11436.22% |
| 2016-06-30 | -9866.81% |
| 2016-03-31 | -8517.60% |
| 2015-12-31 | -9343.04% |
| 2015-09-30 | -4772.32% |
| 2015-06-30 | -20360.00% |
| 2015-03-31 | -5650.45% |
| 2014-12-31 | -8362.50% |
| 2014-09-30 | -9397.40% |
| 2014-06-30 | -1936.24% |
| 2014-03-31 | -2874.91% |
| 2013-12-31 | -2172.23% |
| 2013-09-30 | -10058.58% |
| 2013-06-30 | -10755.29% |
| 2013-03-31 | -932.39% |
| 2012-12-31 | -3880.98% |
| 2012-09-30 | -307.43% |
| 2012-06-30 | -8256.41% |
| 2012-03-31 | -3404.22% |
| 2011-12-31 | -3695.81% |
| 2011-09-30 | 16.85% |
| 2011-06-30 | -562.41% |
| 2011-03-31 | -619.64% |
| 2010-12-31 | -466.67% |
| 2010-09-30 | -11900.00% |
| 2010-06-30 | -2600.00% |
| 2010-03-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 0.00% |
| 2005-04-30 | 0.00% |
| 2005-01-31 | 0.00% |
| 2003-10-31 | 0.00% |
| 2003-07-31 | 0.00% |
| 2003-04-30 | 0.00% |
